CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS
Thursday, May 29, 2014
Photos of the day’s events included with each article!
|
|
|
| Tolerance-Directed Immunotherapies: The Future of MS Treatment?
Precisely targeted therapies that establish immune cell tolerance of specific antigens may enable clinicians to move in coming years from managing the symptoms of MS and other autoimmune diseases via immunosuppression to shutting down the underlying disease processes on a long-term or even permanent basis…Â Read More |
 Stephen D. Miller, PhD |
|
|
|
| Diet and MS: Guiding Smart Patient Choices by Encouraging a Broad Focus, Simple Steps
While patients often are intensely interested in whether a specific food or diet can alter the course of their multiple sclerosis (MS), they ultimately are best served by a broader approach to nutrition that takes into account their overall health, including ameliorating or avoiding co-morbidities, reducing the impact of MS symptoms, and promoting the self-efficacy needed to make sound dietary choices…Â Read More |
 Denise Nowack, RD |
|
|
|
| Different Goals, But a Continued Role, For Neurologists in Late Secondary Progressive MS
Neurologists can and should continue to play an important role in the care of patients with late secondary progressive multiple sclerosis (MS), albeit with different goals and interventions than those that mark their management of patients in earlier stages of MS, R. Philip Kinkel, MD, said yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX…Â Read More |
 R. Philip Kinkel, MD |
|
|
|
| Research Explores Harnessing Beneficial Aspects of Inflammation for MS Interventions
The detrimental role of inflammation in the immunopathology of multiple sclerosis (MS) is well known but represents only one facet of a nuanced – and potentially encouraging – story, Suhayl Dhib-Jalbut, MD, said yesterday during a Clinical Course at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX…Â Read More |
 Suhayl Dhib-Jalbut, MD |
|
|
|
| Converging Trends Assure Vital Role for NPs in MS Patient Care, Research
Several trends are converging to enhance the centrality of nurse practitioners to the management of patients with multiple sclerosis (MS) and to MS research, Stephanie Agrella, RN, MSN, APRN, ANP-BC, MSCN, told attendees at a Clinical Course yesterday at the 2014 Cooperative Meeting of CMSC and ACTRIMS in Dallas, TX…Â Read More |
 Stephanie Agrella, RN, MSN, APRN, ANP-BC, MSCN |
|
|
|
| Realizing the Promise, Avoiding the Pitfalls, of Stem Cell Therapy in MS
Stem cell therapies hold out the promise of repairing the damage done by multiple sclerosis (MS), but realizing that promise will require a rigorous approach that steers clear of lurking pitfalls and ensures that patient safety remains the paramount concern, Mark Freedman, MD, told attendees at a |
 Mark S. Freedman, MD |
|
|
|
| Francois Bethoux, MD, Takes Editorial Helm at the International Journal of MS Care, Outlines Plans
The new Editor in Chief of the International Journal of MS Care (IJMSC), the leading peer-reviewed publication on multiple sclerosis (MS) comprehensive care, will build on the foundation established by his predecessor by continuing to expand the breadth of topics covered in the journal and by further identifying and responding to readers’ information needs…Â Read More |
 Francois Bethoux, MD |
© 2014, Delaware Media Group, Inc. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this publication are those of the presenters and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, or Biogen Idec.
